METHOD OF IDENTIFYING A SKIN-LIGHTENING AGENT

    公开(公告)号:EP2831272B8

    公开(公告)日:2018-11-21

    申请号:EP13715106.4

    申请日:2013-03-27

    IPC分类号: C12Q1/6883 C12N15/10

    摘要: A system for identifying connections between perturbagens and genes associated with a skin hyperpigmentation condition. The system includes a computer readable medium having a plurality of instances stored thereon, and a skin hyperpigmentation-relevant gene expression signature. Each instance includes an instance list of rank-ordered identifiers of differentially expressed genes, and the hyperpigmentation-relevant gene expression signature includes a gene expression signature list of identifiers representing differentially expressed genes associated with a hyperpigmentation condition or differentially expressed genes associated with a benchmark skin-lightening agent. The system also includes a programmable computer with computer-readable instructions that allow the computer to accessing the instances and a hyperpigmentation-relevant gene expression signature stored on the computer readable medium, comparing the hyperpigmentation-relevant gene expression signature to the plurality of the instances, and/or assigning a connectivity score to each of the plurality of instances.

    DETECTING CHROMOSOMAL ANEUPLOIDY
    6.
    发明授权

    公开(公告)号:EP2977466B1

    公开(公告)日:2018-09-19

    申请号:EP15175962.8

    申请日:2015-07-08

    发明人: Chan, Chia-Han

    IPC分类号: C12Q1/68 G06F19/18

    摘要: A method for detecting a chromosomal aneuploidy relating to a target nucleic acid region includes the following steps. A reference database is obtained. At least one normalizing factor is determined based on the reference database. A cutoff value is determined based on the reference database. A biological sample under test is sequenced by the sequencing platform to obtain a number of target reads of the biological sample under test. The target reads of the biological sample under test originate from the target nucleic acid region. The number of the target reads of the biological sample under test is normalized by the normalizing factor and then is compared with the cutoff value. Whether the chromosomal aneuploidy relating to the target nucleic acid region is present in the fetus is determined based on the comparison.

    STRUCTURE BASED DESIGN OF D-PROTEIN LIGANDS
    9.
    发明公开

    公开(公告)号:EP3369023A1

    公开(公告)日:2018-09-05

    申请号:EP16788669.6

    申请日:2016-10-27

    IPC分类号: G06F19/16 G06F19/18 G06F19/00

    摘要: A method of designing a D-polypeptide that binds with an L-target protein can include: identifying a polypeptide target having L-chirality; determining hotspot amino acids of a polypeptide ligand having L-chirality that have binding interactions with the L-target protein; determining transformations of side chains of the hotspot amino acids that retain the binding interactions with the target; generating inversed hotspot amino acids with chirality opposite to the one of the target; identifying a polypeptide having inverse chirality from the target protein, on which a combination of inversed hotspot amino-acid can be grafted without significantly changing their interactions with the target. The designed ligands can be processed and converted to D-ligands that bind with the L-target protein.